Gabriel De La Llave Balderas
Zinzinokunde
Velkommen! Jeg har haft gode resultater med mine produkter og jeg tror, at du også vil elske dem. Lad mig høre, hvad du tænker!
Press releases - 7. marts 2019 12:00 CET
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2019
STRONG SALES GROWTH DURING FEBRUARY; ZINZINO BASED REVENUE INCREASED 21% AND THE TOTAL GROUP REVENUE WITH 18% COMPARED WITH THE PREVIOUS YEAR.
The revenue for Zinzino's sales markets increasing by 21% to SEK 50.1 (41.4) million. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 22% and amounted to SEK 2.9 (3.7) million. Overall, the Group increased revenues by 18% to SEK 53.0 (45.1) million compared with the previous year.
Accumulated revenues for January-February increased with 16% to 106,5 (91,9) MSEK compared with the previous year.
Revenues distributed as follows:
Regions, MSEK | Febr-19 | Febr-18 | Change | 2019 | 2018 | Change |
Nordic Countries | 29.8 | 31.2 | -4% | 60.7 | 61.7 | -2% |
Baltic States | 4.7 | 3.6 | 29% | 9.0 | 7.3 | 23% |
Rest of Europa | 13.6 | 5.1 | 168% | 26.6 | 9.4 | 182% |
North America | 2.0 | 1.5 | 29% | 3.7 | 3.2 | 16% |
Zinzino | 50.1 | 41.4 | 21% | 100.0 | 81.6 | 23% |
Faun Pharma | 2.9 | 3.7 | -22% | 6.5 | 10.3 | -37% |
Zinzino Group | 53.0 | 45.1 | 18% | 106,5 | 91.9 | 16% |
For more information please contact:
Dag Bergheim Pettersen, CEO Zinzino, tel. +47 (0) 932 25 700 www.zinzino.se
Pictures for free publication:
Marcus Tollbom, tel. +46 (0) 70-190 03 12
Certified Adviser:
Erik Penser Bank Aktiebolag: +46 (0)8 463 83 00 Email: certifiedadviser@penser.se
Del denne side
Eller kopiér linket